Marie Viala

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Chemotherapy Induced

Small Cell Lung Cancer

Angiotensin Converting Enzyme

Top Venues

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Quentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, Cesar Lefevbre, Sarah Cavaillon, Léa Sinoquet, Stéphane Pouderoux, Marie Viala, Lise Roca, Xavier Quantin
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study. Cancers 16 (5) (2024)
Quentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, Cesar Lefevbre, Sarah Cavaillon, Léa Sinoquet, Stéphane Pouderoux, Marie Viala, Lise Roca, Xavier Quantin
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study. Cancers 16 (5) (2024)
Julien Colard-Thomas, Quentin Dominique Thomas, Marie Viala
Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications. Cancers 15 (8) (2023)
Julien Colard-Thomas, Quentin Dominique Thomas, Marie Viala
Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications. Cancers 15 (8) (2023)
Marie Viala, Marie Alexandre, Simon Thezenas, Pierre-Jean Lamy, Aurélie Maran-Gonzalez, Marian Gutowski, Pierre-Emmanuel Colombo, Gilles Romieu, William Jacot, Severine Guiu
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers. Breast cancer research and treatment 165 (3) (2017)